Early research (Phase 1)Study completedNCT00630058What this trial is testingMP-424, Peginterferon Alfa 2b, and Ribavirin in Hepatitis CWho this might be right forHepatitis C Tanabe Pharma Corporation 20
Large-scale testing (Phase 3)Study completedNCT01939197What this trial is testingA Multipart, Open-label Study to Evaluate the Safety and Efficacy of ABT-450/r/ABT-267 With and Without ABT-333 Coadministered With and Without Ribavirin in Adult With Genotype 1 or 4 Hepatitis C Virus (HCV) Infection and Human Immunodeficiency Virus, Type 1 CoinfectionWho this might be right forHepatitis C Virus InfectionHuman Immunodeficiency Virus InfectionChronic Hepatitis C+1 more AbbVie 318
Testing effectiveness (Phase 2)Study completedNCT01121731What this trial is testingA Phase I/II Clinical Trial With Interferon Alfa 5 in Treatment-Experienced Patients With Genotype-1 Chronic Hepatitis CWho this might be right forChronic Hepatitis C Virus InfectionGenotype 1Treatment-Experienced Patients+1 more Digna Biotech S.L. 70
Testing effectiveness (Phase 2)UnknownNCT01024894What this trial is testingDose Escalation Study of Interleukin-7 (IL-7) and Bitherapy in Asiatic HCV Patients Resistant to BitherapyWho this might be right forHepatitis C Cytheris SA 15
Early research (Phase 1)Study completedNCT00823862What this trial is testingSafety Study of SD-101 (a Novel C Type Toll-like Receptor 9 (TLR9) Agonist) for the Treatment of Chronic Hepatitis C Virus (HCV) InfectionWho this might be right forChronic Hepatitis C Dynavax Technologies Corporation 34
Testing effectiveness (Phase 2)Study completedNCT01899092What this trial is testingSafety and Efficacy Study of Single Doses of TT-034 in Patients With Chronic Hepatitis CWho this might be right forHepatitis C Tacere Therapeutics, Inc. 9
Large-scale testing (Phase 3)Study completedNCT01854697What this trial is testingEvaluate the Efficacy and Safety of Three Experimental Drugs Compared With Telaprevir (a Licensed Product) in People With Hepatitis C Virus Infection Who Have Not Had Treatment BeforeWho this might be right forChronic Hepatitis C Infection AbbVie 311
Early research (Phase 1)Study completedNCT00591214What this trial is testingSafety and PK Study of MP-424 to Treat Chronic Hepatitis CWho this might be right forChronic Hepatitis C Tanabe Pharma Corporation 10
Testing effectiveness (Phase 2)UnknownNCT02057887What this trial is testingSafety,Tolerability and Pharmacokinetic Study of Recombinant Human Interferon Alfa 2B in Chronic Hepatitis C Patients (HM10660A)Who this might be right forChronic Hepatitis C Virus Genotype I Hanmi Pharmaceutical Company Limited 64
Testing effectiveness (Phase 2)WithdrawnNCT01142700What this trial is testingBMS-824393 in Combination With Peginterferon Alfa-2a (Pegasys) and Ribavirin (Copegus) in Treatment Naive Subjects With Chronic Hepatitis C Virus Genotype IWho this might be right forChronic Hepatitis C Virus Genotype 1 Bristol-Myers Squibb
Large-scale testing (Phase 3)Study completedNCT02219490What this trial is testingEvaluate Long-term Outcomes Following Treatment With ABT-450/Ritonavir/ABT-267 (ABT-450/r/ABT-267) and ABT-333 With or Without Ribavirin (RBV) in Adults With Genotype 1 Chronic Hepatitis C Virus (HCV) InfectionWho this might be right forChronic Hepatitis C Virus (HCV) Infection Genotype 1 AbbVie 1,596
Testing effectiveness (Phase 2)Study completedNCT00807001What this trial is testingDouble-Blind, Dose-Escalation Study of IDX184 in Chronic Hepatitis C Treatment-Naïve SubjectsWho this might be right forChronic Hepatitis C (HCV) Merck Sharp & Dohme LLC 41
Not applicableEnded earlyNCT02315638What this trial is testingLong-Term Follow-Up Safety Monitoring of Patients Dosed in the First-in-Man Phase I/II Study of TT-034.Who this might be right forHepatitis C Tacere Therapeutics, Inc. 9
Testing effectiveness (Phase 2)Study completedNCT03593447What this trial is testingTo Evaluate Efficacy and Safety in TG-2349 Combination With DAG181 (± Ribavirin) in HCV Genotype I Infected PatientsWho this might be right forChronic Hepatics C Virus (HCV) Genotype 1Non-CirrhoticCirrhosis+1 more Dongguan HEC TaiGen Biopharmaceuticals Co., Ltd. 133
Early research (Phase 1)Ended earlyNCT00277758What this trial is testingSafety Study of Low Dose Interleukin 2 (IL-2) Plus PEG-IFN/RBV In Chronic Hepatitis C Virus Genotype IWho this might be right forHepatitis C Weill Medical College of Cornell University 18
Large-scale testing (Phase 3)Study completedNCT01716585What this trial is testingEvaluate Chronic Hepatitis C InfectionWho this might be right forChronic Hepatitis C Infection AbbVie (prior sponsor, Abbott) 636
Testing effectiveness (Phase 2)Study completedNCT01685203What this trial is testingEvaluate the Safety and Effect of Co-administration of ABT-450 With Ritonavir (ABT-450/r) and ABT-267 in Adults With Chronic Hepatitis C Virus InfectionWho this might be right forHepatitis C, Chronic AbbVie (prior sponsor, Abbott) 316
Testing effectiveness (Phase 2)Study completedNCT01025596What this trial is testingDose Escalation Study of IL-7 and Bi-therapy in HCV Patients Resistant After 12 Weeks of Bi-therapy (ECLIPSE 1)Who this might be right forHepatitis C Cytheris SA 10
Testing effectiveness (Phase 2)Study completedNCT02243280What this trial is testingEvaluate the Efficacy, Safety, and Pharmacokinetics of Co-administration of ABT-493 and ABT-530 With and Without Ribavirin in Subjects With HCV Genotype 1, 4, 5, and 6 InfectionWho this might be right forChronic Hepatitis CHepatitis C VirusHCV AbbVie 174
Testing effectiveness (Phase 2)UnknownNCT00563173What this trial is testingPhase I/IIa Dose Ranging CHRONVAC-C® Study in Chronic HCV PatientsWho this might be right forChronic Hepatitis C Virus Infection Tripep AB 12